Effect of Intensity of Home Noninvasive Ventilation in Individuals With Neuromuscular and Chest Wall Disorders: A Systematic Review and Meta-Analysis of Individual Participant Data.

Humans Noninvasive Ventilation / methods Thoracic Wall Respiratory Insufficiency / etiology Respiration, Artificial Pulmonary Disease, Chronic Obstructive Hypercapnia / etiology
Chest wall disorders Meta-analysis Neuromuscular diseases Noninvasive ventilation Systematic review

Journal

Archivos de bronconeumologia
ISSN: 1579-2129
Titre abrégé: Arch Bronconeumol
Pays: Spain
ID NLM: 0354720

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 28 02 2023
revised: 04 05 2023
accepted: 05 05 2023
medline: 4 8 2023
pubmed: 23 5 2023
entrez: 22 5 2023
Statut: ppublish

Résumé

Home noninvasive ventilation (NIV), targeting a reduction of carbon dioxide with a combination of sufficient inspiratory support and backup-rate improves outcomes in patients with chronic obstructive pulmonary disease. The aim of this systematic review with individual participant data (IPD) meta-analysis was to evaluate the effects of intensity of home NIV on respiratory outcomes in individuals with slowly progressive neuromuscular (NMD) or chest-wall disorders (CWD). Controlled, non-controlled and cohort studies indexed between January-2000 and December-2020 were sought from Medline, Embase and the Cochrane Central Register. Outcomes were diurnal PaCO 16 eligible studies were identified; we obtained IPD for 7 studies (176 participants: 113-NMD; 63-CWD). The reduction in PaCO Following home NIV initiation in NMD or CWD patients, no relationship was observed between NIV intensity and PaCO

Identifiants

DOI: 10.1016/j.arbres.2023.05.002 PMID: 37217384
pubmed: 37217384
pii: S0300-2896(23)00156-4
doi: 10.1016/j.arbres.2023.05.002
pii:
doi:

Types de publication

Meta-Analysis Systematic Review Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

488-496

Informations de copyright

Copyright © 2023 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

Mathieu Delorme (M)

Université Paris-Saclay, UVSQ, ERPHAN, Versailles, France; AFM-Téléthon, Direction des Actions Médicales, Evry, France.

Antoine Leotard (A)

Service de Physiologie et explorations fonctionnelles, GHU APHP - Paris Saclay - Hôpital Raymond Poincaré (APHP), Garches, France; Université Paris-Saclay, UVSQ, INSERM U1179, Equipe 3 «END:ICAP», Versailles, France.

Marius Lebret (M)

Université Paris-Saclay, UVSQ, ERPHAN, Versailles, France.

Claire Lefeuvre (C)

Neurology Department, Raymond Poincaré University Hospital, Garches, APHP, France; Nord-Est-Ile-de-France Neuromuscular Reference Center, FHU PHENIX, France.

Anda Hazenberg (A)

University of Groningen, University Medical Center Groningen, Department of Pulmonology and Tuberculosis, Department of Home Mechanical Ventilation, Groningen, The Netherlands; University of Groningen, University Medical Center Groningen, GRIAC Research Institute, The Netherlands.

Mercedes Pallero (M)

Respiratory Medicine Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain; CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.

Annabel H Nickol (AH)

Oxford Centre for Respiratory Medicine, Oxford University Hospital NHS Foundation Trust, Oxford, UK; The Royal Brompton Hospital, London, UK.

Liam M Hannan (LM)

Department of Respiratory Medicine, Northern Health, Melbourne, Victoria, Australia; Institute for Breathing and Sleep, Melbourne, Australia; Dept of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia.

Matthias Boentert (M)

Department of Neurology, Münster University Hospital (UKM), Münster, Germany; Department of Medicine, UKM-Marienhospital Steinfurt, Steinfurt, Germany.

Aycan Yüksel (A)

Ufuk University, Faculty of Medicine, Rıdvan Ege Hospital, Department of Pulmonology and Tuberculosis, Ankara, Turkey.

Wolfram Windisch (W)

Cologne Merheim Hospital, Department of Pneumology, Kliniken der Stadt Köln, gGmbH, Witten/Herdecke University, Germany.

Mark E Howard (ME)

Institute for Breathing and Sleep, Melbourne, Australia; Dept of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Australia; Turner Institute for Brain and Mental Health, Monash University, Melbourne, Australia.

Nicholas Hart (N)

Lane Fox Clinical Respiratory Physiology Research Centre, Guy's and St Thomas' NHS Foundation Trust, London, UK; Centre for Human and Applied Physiological Science, King's College London, London, UK.

Peter J Wijkstra (PJ)

University of Groningen, University Medical Center Groningen, Department of Pulmonology and Tuberculosis, Department of Home Mechanical Ventilation, Groningen, The Netherlands; University of Groningen, University Medical Center Groningen, GRIAC Research Institute, The Netherlands.

Hélène Prigent (H)

Service de Physiologie et explorations fonctionnelles, GHU APHP - Paris Saclay - Hôpital Raymond Poincaré (APHP), Garches, France; Université Paris-Saclay, UVSQ, INSERM U1179, Equipe 3 «END:ICAP», Versailles, France; FHU Phenix - GHU APHP - Paris Saclay - Hôpital Raymond Poincaré (APHP), Garches, France.

Jean-Louis Pepin (JL)

HP2 (Hypoxia and Physio-Pathologies) Laboratory, Inserm (French National Institute of Health and Medical Research), University Grenoble Alpes, Grenoble, France; EFCR (Cardiovascular and Respiratory Function) Laboratory, Grenoble Alpes University Hospital, Grenoble, France.

Frederic Lofaso (F)

Université Paris-Saclay, UVSQ, ERPHAN, Versailles, France; Service de Physiologie et explorations fonctionnelles, GHU APHP - Paris Saclay - Hôpital Raymond Poincaré (APHP), Garches, France.

Charles Khouri (C)

HP2 (Hypoxia and Physio-Pathologies) Laboratory, Inserm (French National Institute of Health and Medical Research), University Grenoble Alpes, Grenoble, France; Centre Régional de pharmacovigilance, Centre d'Investigation Clinique, CHU Grenoble Alpes, France.

Jean-Christian Borel (JC)

HP2 (Hypoxia and Physio-Pathologies) Laboratory, Inserm (French National Institute of Health and Medical Research), University Grenoble Alpes, Grenoble, France; Research and Development Department, AGIR à dom Association, Meylan, France. Electronic address: j.borel@agiradom.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Effect of Intensity of Home Noninvasive...
questionsmedicales.fr › Thérapeutique › Thérapie respiratoire › Ventilation artificielle › Ventilation non effractive › Effect of Intensity of Home Noninvasive...
questionsmedicales.fr › Régions du corps › Tronc › Thorax › Paroi thoracique › Effect of Intensity of Home Noninvasive...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Troubles respiratoires › Insuffisance respiratoire › Effect of Intensity of Home Noninvasive...
questionsmedicales.fr › Thérapeutique › Thérapie respiratoire › Ventilation artificielle › Effect of Intensity of Home Noninvasive...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladie chronique › Broncho-pneumopathie chronique obstructive › Effect of Intensity of Home Noninvasive...
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Signes et symptômes respiratoires › Hypercapnie › Effect of Intensity of Home Noninvasive...